|
1
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual report to the nation on the status of cancer,
1975–2012, featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Zucman-Rossi J, Pikarsky E,
Sangro B, Schwartz M, Sherman M and Gores G: Hepatocellular
carcinoma. Nat Rev Dis Primers. 2:160182016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janevska D, Chaloska-Ivanova V and
Janevski V: Hepatocellular carcinoma: Risk factors, diagnosis and
treatment. Open Access Maced J Med Sci. 3:732–736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Negash AA, Olson RM, Griffin S and Gale M
Jr: Modulation of calcium signaling pathway by hepatitis C virus
core protein stimulates NLRP3 inflammasome activation. PLoS Pathog.
15:e10075932019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang F, Yu X, Zhou C, Mao R, Zhu M, Zhu H,
Ma Z, Mitra B, Zhao G, Huang Y, et al: Hepatitis B e antigen
induces the expansion of monocytic myeloid-derived suppressor cells
to dampen T-cell function in chronic hepatitis B virus infection.
PLoS Pathog. 15:e10076902019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi L, Zhang W, Zou F, Mei L, Wu G and
Teng Y: KLHL21, a novel gene that contributes to the progression of
hepatocellular carcinoma. BMC Cancer. 16:8152016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen HC, Jeng YM, Yuan RH, Hsu HC and Chen
YL: SIRT1 promotes tumorigenesis and resistance to chemotherapy in
hepatocellular carcinoma and its expression predicts poor
prognosis. Ann Surg Oncol. 19:2011–2019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee JW, Soung YH, Kim SY, Lee HW, Park WS,
Nam SW, Kim SH, Lee JY, Yoo NJ and Lee SH: PIK3CA gene is
frequently mutated in breast carcinomas and hepatocellular
carcinomas. Oncogene. 24:1477–1480. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. April 15;200 (Epub ahead of print). doi:
10.1093/hmg/ddl046.
|
|
11
|
Hauptman N and Glavac D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reddy KB: MicroRNA (miRNA) in cancer.
Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qi P and Du X: The long non-coding RNAs, a
new cancer diagnostic and therapeutic gold mine. Mod Pathol.
26:155–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie J, Xie G, Chen Q, Xu Z, Bai W and Chen
M: Identification of a novel lncRNA GABPB1-IT1 that is
downregulated and predicts a poor prognosis in non-small cell lung
cancer. Oncol Lett. 18:838–845. 2019.PubMed/NCBI
|
|
15
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang H, Bu Q, Zeng M, Xia D and Wu A:
MicroRNA-93 promotes bladder cancer proliferation and invasion by
targeting PEDF. Urol Oncol. 37:150–157. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lei HJ, Chau GY, Lui WY, Tsay SH, King KL,
Loong CC and Wu CW: Prognostic value and clinical relevance of the
6th Edition 2002 American Joint Committee on Cancer staging system
in patients with resectable hepatocellular carcinoma. J Am Coll
Surg. 203:426–435. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Higuchi T, Oshiro H, Zhang Z, Miyake K,
Sugisawa N, Katsuya Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, et
al: Osimertinib regresses an EGFR-mutant cisplatinum-resistant lung
adenocarcinoma growing in the brain in nude mice. Transl Oncol.
12:640–645. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun X, Zheng G, Li C and Liu C: Long
non-coding RNA Fer-1-like family member 4 suppresses hepatocellular
carcinoma cell proliferation by regulating PTEN in vitro and
in vivo. Mol Med Rep. 19:685–692. 2019.PubMed/NCBI
|
|
21
|
Mann M, Wright PR and Backofen R: IntaRNA
2.0: Enhanced and customizable prediction of RNA-RNA interactions.
Nucleic Acids Res. 45:W435–W439. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hausser J and Zavolan M: Identification
and consequences of miRNA-target interactions-beyond repression of
gene expression. Nat Rev Genet. 15:599–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Forner A and Bruix J: Biomarkers for early
diagnosis of hepatocellular carcinoma. Lancet Oncol. 13:750–751.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Altekruse SF, Henley SJ, Cucinelli JE and
McGlynn KA: Changing hepatocellular carcinoma incidence and liver
cancer mortality rates in the United States. Am J Gastroenterol.
109:542–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Yao W, Yuan Y, Chen P, Li B, Li J,
Chu R, Song H, Xie D, Jiang X and Wang H: Targeting of
tumour-infiltrating macrophages via CCL2/CCR2 signalling as a
therapeutic strategy against hepatocellular carcinoma. Gut.
66:157–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Yang G, Zhu X, Wang Z, Wang H, Bai
Y, Sun P, Peng L, Wei W, Chen G, et al: miR-93-3p inhibition
suppresses clear cell renal cell carcinoma proliferation,
metastasis and invasion. Oncotarget. 8:82824–82834. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Leontis NB, Zirbel CL, Bisaro DM and
Ding B: A three-dimensional RNA motif mediates directional
trafficking of Potato spindle tuber viroid from epidermal to
palisade mesophyll cells in Nicotiana benthamiana. PLoS Pathog.
15:e10081472019. View Article : Google Scholar : PubMed/NCBI
|
